Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Nat. Prod.

Sec. Biological Activities of Natural Products

Volume 4 - 2025 | doi: 10.3389/fntpr.2025.1625451

This article is part of the Research TopicBridging Traditional and Modern Medicine: The Role of Botanicals in HealthcareView all 6 articles

Novel prospectives of Paeonia lactiflora root extract as a natural modulator of LPS-induced inflammation and collagen I synthesis in skin and oral gingival cells

Provisionally accepted
Viktor  FilatovViktor Filatov1*Alina  YarovayaAlina Yarovaya2Egor  IlinEgor Ilin2Elizaveta  PatronovaElizaveta Patronova3Vadim  TashlitskyVadim Tashlitsky2Elena  KalenikovaElena Kalenikova1
  • 1Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia
  • 2Deparment of Chemistry, Lomonosov Moscow State University, Moscow, Russia
  • 3Institute of Biomedical Systems and Biotechnology, Peter the Great St.Petersburg Polytechnic University, Saint Petersburg, Russia

The final, formatted version of the article will be published soon.

Paeonia lactiflora Pall. (P. lactiflora) has long been used in traditional medicine for pain relief. Paeoniflorin as the main glucoside of P. lactiflora root extract could determine its pharmacological effects. Thus, the research was aimed at investigation of P. lactiflora root extract as a natural modulator of LPS-induced inflammation and I type collagen synthesis in skin and oral gingival cells. Transient receptor potential vanilloid 1 (TRPV1) channel and matrix metalloproteinases (MMPs) were chosen as the main targets for paeoniflorin in the P. lactiflora extract in silico. Maximum tolerated concentration was evaluated on keratinocytes as 0.5 mg/mL through MTT assay. In vitro study was conducted to determine the effects of P. lactiflora extract on LPS-induced inflammation and tissue destruction markers in skin keratinocytes, dermal and gingival fibroblasts using ELISA. Firstly, the standardized extract at concentrations of 0.03 mg/mL, 0.1 mg/mL and 0.5 mg/mL reduced TRPV1 amount in skin keratinocytes by 38.06%, 52.24% and 67.05% (P<0.001). Secondly, it was demonstrated that the extract at concentration of 0.5 mg/mL eliminated inflammatory stress induced by LPS reducing the production of TNF-α and production of IL-6 and IL-13 up to 25% (P<0.01) and 55% (P<0.001). Moreover, the extract demonstrated a protective effect on tissues destruction by reducing MMP-9 production by 70.27% in dermal fibroblasts and MMP-8 production by 39.32% in gingival fibroblasts (P<0.001). Furthermore, the extract restored I type collagen amount to initial level in dermal and gingival fibroblasts. Thus, P. lactiflora extract containing paeoniflorin is a promising natural modulator of LPS-induced inflammation in skin and oral gingival cells, providing complex protection against I type collagen destruction.

Keywords: paeoniflorin, Paeonia lactiflora extract, TRPV1, MMP-8, MMP-9, collagen I, Inflammation, tissue destruction

Received: 08 May 2025; Accepted: 04 Aug 2025.

Copyright: © 2025 Filatov, Yarovaya, Ilin, Patronova, Tashlitsky and Kalenikova. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Viktor Filatov, Faculty of Fundamental Medicine, Lomonosov Moscow State University, Moscow, Russia

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.